prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, AP Surgical Pathology: Additional Info. I. CLINICAL HISTORY: of known carcinoma right 10:00 breast. If invasive carcinoma, please results. Biopsy obtain ER, PR, EGFR, HER2/Neu by immunohistochemistry; for all 2+ IHC. please do FISH analysis. A. GROSS "USNCB right breast, five cores 10:00 area". Received in formalin is a 1.7 in. EXAMINATION: x. 1 x 0.2 cm aggregate of fibrofatty needle core tissue submitted entirely. a mesh bag in block A1. MICROSCOPIC EXAMINATION: Microscopic examination is performed. DIAGNOSIS: A. "USNCB RIGHT BREAST, FIVE CORES 10:00 AREA": INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: DUCTAL. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 3 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 3. MITOTIC RATE SCORE: 3. LYMPHATIC/VASCULAR INVASION: NOT IDENTIFIED. IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: COMEDO. NUCLEAR GRADE OF IN-SITU CARCINOMA: 3 OF 3. MICROCALCIFICATIONS ABSENT. ESTROGEN/PROGESTERONE RECEPTOR, HER2/NEU, AND EGFR ANALYSIS: PENDING. PARAFFIN BLOCK NUMBER: A1. RESULTS WILL BE ISSUED IN AN ADDENDUM. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . AT ADDENDUM 1: for results of supplementary. Please see. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). Attending MD: T.

expanded version (tokens=823) : 
 Based on the information in the report, here is a summary of the key points:

- The patient has a known carcinoma in the right 10:00 breast area.
- The biopsy obtained ER, PR, EGFR, and HER2/Neu receptor status via immunohistochemistry testing, with FISH analysis to be done for any results that are 2+.
- The gross examination revealed five cores of fibrofatty needle core tissue from the 10:00 area of the right breast.
- Microscopic examination showed invasive ductal carcinoma of the breast, with a combined histologic grade of 3 out of 3 using the Nottingham scoring system.
- The in-situ carcinoma present was of the comedo type with a nuclear grade of 3 out of 3.
- No lymphatic or vascular invasion was identified, and microcalcifications were absent.
- Estrogen/progesterone receptor, HER2/NEU, and EGFR analysis results are pending, to be issued in an addendum.
- The attending MD is T.

In summary, the patient has invasive ductal carcinoma of the breast, with concurrent in-situ comedo carcinoma and a high combined histologic grade. Ancillary testing results, including receptor status, are pending and will be provided in an addendum to the report.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=931) : 
 The report describes a known carcinoma in the right breast, diagnosed as invasive ductal with comedo and high histologic grade. No evidence of lymphatic or vascular invasion, microcalcifications absent. Estrogen/progesterone receptor, HER2/Neu, and EGFR analyses are pending.

